SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children
Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field
We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
